HER2newC apoptosis inducer (IcanoMAB)

N/A

Report date: 2024/11/04 16:01:02
NME

Base Information

Drug NameHER2newC apoptosis inducer (IcanoMAB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-HER2
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcanoMAB GmbH
China Registration ClassN/A

Develop Information

Active CompaniesIcanoMAB GmbH
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A